Association between hypernatraemia acquired in the ICU and mortality: a cohort study 
Introduction
Hypernatraemia, defined as serum sodium elevation to >145 mmol/L, is common when inadequate water intake occurs along with hypotonic fluid losses. This condition has been extensively studied in the elderly and in patients with neuropsychiatric diseases [1, 2] . The various physiological consequences of hypernatraemia may be life-threatening [3] [4] [5] .
In a general medical-surgical population of non-critically ill patients, the prevalence of hypernatraemia has been estimated at up to 1% [6, 7] . Considerably higher prevalences of 10-26% are seen in critically ill patients, in whom major risk factors for hypernatraemia are mechanical ventilation, coma and sedation [2, [8] [9] [10] [11] [12] . Although hypernatraemia may be present at admission to the intensive care unit (ICU), it develops during the ICU stay in about three-quarters of cases [9] [10] [11] [12] . In these patients, renal water loss, inability to express thirst and inadequate fluid management by ICU physicians appear to be the causative triad. Being ascribable to inadequate adjustment of water intake, ICUacquired hypernatraemia (IAH) should therefore be, at least partly, preventable.
Several studies suggest an association between hypernatraemia and hospital mortality [8] [9] [10] [11] [12] . However, most of them were retrospective single-centre studies in small numbers of patients [9, 10, 12] or focused exclusively on hypernatraemia at ICU admission [8] . Additional shortcomings of these studies include failure to adequately adjust for confounders [9] [10] [11] and competing events [13] , and failure to consider other adverse events occurring during the ICU stay [14] . Furthermore, a few studies were specifically designed to investigate IAH [11, 12] .
Here, our objective was to assess the prevalence of IAH in a large multicentre cohort of patients and to estimate the impact of IAH on mortality after adjustment for confounders. We also looked for the factors associated with IAH.
Materials and methods

Study design and data source
We conducted a retrospective observational study on a prospectively collected multicentre database (OUTCOMEREA; www.outcomerea.org) to assess the epidemiological characteristics and prognostic impact of IAH. The database, fed by 12 French ICUs, collects prospective data on daily disease severity, iatrogenic events and nosocomial infections. Each year, each ICU includes a random sample of at least 50 patients who are older than 16 years and have ICU stays longer than 24 h. Each ICU could choose to obtain the random sample by taking either consecutive admissions to selected ICU beds throughout the year or consecutive admissions to all ICU beds for 1 month.
Study population and definitions
The study was approved by the institutional review board of the Grenoble University Hospital. We included consecutive patients who met the following criteria: age older than 18years, entry in the database between January 1997 and May 2008, and availability of at least two serum sodium measurements. Patients with hypernatraemia at ICU admission were secondarily excluded from the study.
IAH was defined as hypernatraemia with onset at least 24 h after ICU admission. We defined mild hypernatraemia as a serum sodium level >145 mmol/L but <150 mmol/L and moderate to severe hypernatraemia as a serum sodium level >150 mmol/L [8] .
Data collection
Data were collected daily by senior physicians and/or specifically trained study monitors in the participating ICUs. For each patient, the investigators entered the data into a computer case report form using data-capture software (RHEA; OUTCOMEREA) and imported all records into the OUTCOMEREA database. All codes and definitions were established prior to study initiation. The following information was recorded: age and sex, admission category (medical, scheduled surgery or unscheduled surgery), origin (home, ward or emergency department) and McCabe score [15] . McCabe score is a classification evaluating patients' underlying comorbidities (1-non-fatal underlying disease; 2-ultimately fatal underlying disease; 3-rapidly fatal underlying disease). Severity of illness was evaluated on the first ICU day using the Simplified Acute Physiology Score version II (SAPS II) [16] and the Logistic Organ Dysfunction (LOD) score [17] . SAPS II and LOD score were computed using the worse physical and laboratory data recorded during the first 24 h in the ICU. SAPS II score ranges from 0 to 155, with higher scores indicating more severe illness. LOD score ranges from 0 to 22 and increases with the number and the severity of organ failure. Knaus scale definitions were used to record pre-existing chronic organ failures including respiratory, cardiac, hepatic, renal and immune system failure [18] .
Quality of the database
For most of the study variables, the data-capture software immediately ran an automatic check for internal consistency, generating queries that were sent to the ICUs for resolution before incorporation of the new data into the database. In each participating ICU, data quality was checked by having a senior physician from another participating ICU review a 2% random sample of the study data every other year. A 1-day data-capture training course held once a year was open to all the OUTCOMEREA investigators and study monitors. All qualitative variables used in the analyses had κ coefficients >0.6, and all variables had inter-rater coefficients in the 0.67-1 range, indicating good to excellent reproducibility. 
Statistical analysis
Values of categorical variables are reported as numbers (%) and values of continuous variables as medians [interquartile range (IQR)]. The chisquare test was used for categorical data and the Wilcoxon test for continuous data.
Potential risk factors for IAH were entered in a Fine and Gray extension of a Cox model. IAH was handled as a time-dependent variable, and corrections were made for competing risks [19] . Then, we used the Fine and Gray subdistribution hazard regression model [19] , with death in the ICU as the variable of interest. Discharge alive from the ICU was handled as a competing event [13] . IAH was included as a time-dependent variable that was equal to 0 before hypernatraemia onset and 1 from hypernatraemia onset to last follow-up. Last, we adjusted the impact of IAH for a centre effect and for the following potential confounding factors: variables collected at admission (male gender, SAPS II, chronic disease according to the Knaus classification, transfer from a hospital or from another ICU in the same hospital, pneumonia as the main diagnosis, mechanical ventilation at ICU admission, bladder catheter on Day 1 and do-not-resuscitate order at ICU admission) and time-dependent adverse events previously identified by our group as independent risk factors for death (bloodstream infection during the ICU stay, hospital-acquired pneumonia, surgical site infection, pneumothorax during the ICU stay and gastrointestinal bleeding during the ICU stay) [13, 14, 20] . Subdistribution hazard ratios (SHR) and 95% confidence intervals (95% CI) were calculated.
P-values <0.05 were considered significant. Analyses were performed using SAS 9.1 software (SAS Institute; Cary, NC).
Results
Study population
Of the 8441 patients with ICU stays longer than 48 h who were entered into the database during the study period, 301 were excluded because they had hypernatraemia at ICU admission. Among the 8140 remaining patients, 901 (11.1%) experienced mild IAH and 344 (4.2%) moderate to severe IAH (Figure 1) , yielding an overall frequency of 153/1000 ICU admissions. The incidence density of IAH was 35/1000 ICU days overall, 26/1000 ICU days for mild IAH and 9/1000 ICU days for moderate to severe IAH. The time from ICU admission to IAH was 5 days (3-8) for mild cases and 6 days (3-10) for moderate to severe cases ( Figure 2 ).
Risk factors for IAH
Characteristics of patients at ICU admission are reported in Table 1 . Median age of the included patients was of 64 years old (50-76), and 62% of these patients were of male gender. Forty percent of these patients had a McCabe score of 2 or 3 (rapidly or ultimately fatal underlying disease). At ICU admission, the SAPS II was 37 (27-51), and the LOD score was 3 (1-6). Most of the patients were admitted for a medical condition (69.8%), and main symptoms at ICU admission were acute respiratory failure in 2013 patients (11.9%), coma in 1166 patients (14.3%) or septic shock in 855 patients (10.5%). Overall, the group with IAH was older and had larger proportions of males, patients with chronic illnesses as assessed by the McCabe score and patients with greater disease severity.
Factors independently associated with IAH in the Fine and Gray model are reported in Table 2 . Overall, IAH The data are medians (IQR). Body mass index is measured by dividing the weight in kilograms by the square of the height in metres. LOD score can range from 0 to 22, and SAPS II can range from 0 to 155.
was associated with male gender; greater disease severity at ICU admission; and septic shock, acute respiratory failure or coma at ICU admission. Other factors associated with IAH were a need for aggressive treatment at ICU admission including the need for bladder catheter, central venous catheter or vasoactive agents, and the use of steroids or antibiotics.
Outcome of patients with IAH
Before adjustment, hospital mortality was 15.2% in patients without IAH, 29.5% in patients with mild IAH and 46.2% in patients with moderate to severe IAH (Figure 1 ). Table 3 shows the impact of IAH on ICU mortality according to the subdistribution hazard model evaluating IAH as a time-dependent variable. IAH was significantly associated with ICU mortality before adjustment (SHR, 4.26; 95% CI, 3.74-4.84; P < 0.0001). The effect on mortality remained significant after stratification by centre and adjustment for time-dependent and non-time-dependent confounders (Table 3) , the adjusted SHR being 2.45; 95% CI, 2.14-2.80; P < 0.0001. Both severity categories of IAH influenced mortality: the SHR for mild IAH (Na 146-150 mmol/L) was 2.03 (95% CI, 1.73-2.39; P < 0.0001), and the SHR for moderate to severe IAH (Na >150 mmol/L) was 2.67 (95% CI, 2.19-3.26; P < 0.0001).
Discussion
In a large multicentre cohort study focusing specifically on IAH, we found that this electrolyte disorder was common and was an independent risk factor for ICU mortality. In addition, this prognostic impact was retrieved even for mild IAH. Moderate to severe hypernatraemia has been found in 0.2-2.5% of the general in-hospital population [1, 6, 7, 21] . Higher prevalences were reported in geriatric patients [2, 22] . Thirst and access to water are the most important mechanisms that prevent hypernatraemia [5] . Thus, critically ill patients are at high risk for hypernatraemia, as they are often unconscious and/or unable to access water freely. In these patients, either insufficient water administration or inadvertent overcorrection of hypotonic losses by iso-or hypertonic fluids may lead to hypernatraemia [12, 23, 24] . A few studies have assessed the prevalence and prognostic impact of hypernatraemia in critically ill patients [8] [9] [10] [11] [12] . In these studies, which focused on moderate to severe hypernatraemia (>148 or 150 mmol/L) [9, 10, 12] , the prevalence ranged from 10% to 26% [9] [10] [11] [12] , with as many as 80% of cases being acquired during the ICU stay [10] [11] [12] . Our finding that the overall prevalence of hypernatraemia was 15.3% (density incidence, 35/1000 ICU days) in a large multicentre cohort of ICU patients is additional evidence that IAH is a common event.
The most striking result of our study is the strong association between IAH and ICU mortality after adjustment for confounders. Earlier studies also reported an association between hypernatraemia and death [8] [9] [10] [11] [12] but did not consistently handle hypernatraemia as a time-dependent event, adjust for confounders [10, 11] or focus on hypernatraemia at ICU admission [8] . However, a retrospective case-control study suggested that moderate to severe IAH was significantly associated with death [12] . Using a strong statistical method, we confirmed this finding and showed that the risk of death increased not only in patients with moderate to severe IAH but also in those with mild IAH. Given that the main factor in the development of IAH is probably inadequate fluid management [24] , IAH may be largely preventable [5, 12, 24, 25] . Therefore, IAH should be considered a sentinel event in the ICU. It would be of interest to evaluate the potential benefits of interventions aimed at decreasing the prevalence of IAH.
Our study has several limitations. Firstly, the design of our study, retrospective analysis of a prospectively collected database, implies that several of the factors found to be associated with occurrence of IAH may have been surrogates without direct relationship with occurrence of IAH. For example, no data were available to evaluate fluid balance or use of diuretics. However, earlier studies showed that inadequate fluid management was the main cause of IAH [12, 23, 24] . In the same way, we were unable to correct serum sodium for hyperglycaemia in the studied population, and hyperglycaemia was not included as one of the potential confounding factors when evaluating association between mortality and IAH [26] . Last, we were unable to determine why IAH was associated with an increased risk of death. A role for IAH in death is biologically plausible. Nevertheless, we cannot determine from our data whether the association between IAH and mortality reflected a direct effect of hypernatraemia or constituted a marker for suboptimal quality of care. Additional studies are needed to investigate this issue. Our results confirm the high prevalence of IAH and demonstrate that IAH is an independent risk factor for ICU mortality. Prompt identification of patients at risk for IAH and early adaptation of the fluid balance may diminish the risk of IAH. The efficacy of this approach and its impact on ICU mortality remain to be evaluated.
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